These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers. Wang Y, Lee L, Somma R, Thompson G, Bakhtiar R, Lee J, Rekhi GS, Lau H, Sedek G, Hossain M. Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557 [Abstract] [Full Text] [Related]
4. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance. Weinling E, McDougall S, Andre F, Bianchetti G, Dubruc C. Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025 [Abstract] [Full Text] [Related]
7. Relative bioavailability of tizanidine 4-mg capsule and tablet formulations after a standardized high-fat meal: a single-dose, randomized, open-label, crossover study in healthy subjects. Henney HR, Shah J. Clin Ther; 2007 Apr; 29(4):661-9. PubMed ID: 17617289 [Abstract] [Full Text] [Related]
8. Plasma concentrations of isosorbide dinitrate after oral administration of a sustained-release formulation to human subjects. Assinder DF, Chasseaud LF, Hunter JO, Jung RJ, Taylor T. Arzneimittelforschung; 1977 Apr; 27(1):156-8. PubMed ID: 576817 [Abstract] [Full Text] [Related]
9. In vivo/in vitro correlations for four differently dissolving ketorolac tablets. Gordon MS, Chowhan Z. Biopharm Drug Dispos; 1996 Aug; 17(6):481-92. PubMed ID: 8866039 [Abstract] [Full Text] [Related]
10. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation. Nosaka H, Takagi K, Hasegawa T, Ogura Y, Mizukami Y, Satake T. Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672 [Abstract] [Full Text] [Related]
11. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers. Deroubaix X, Lins RL, Lens S, Demblon C, Jeanbaptiste B, Poelaert D, Stockis A. Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748 [Abstract] [Full Text] [Related]
12. The bioavailability and kinetics of dihydroquinidine in patients with heart disease. Regazzi Bonora M, Salerno JA, Rondanelli R, Cristiani D, Chimienti M. Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):212-8. PubMed ID: 7095920 [Abstract] [Full Text] [Related]
17. [Pharmacokinetics of clonidine and chlorthalidone following subacute administration of a fixed combination compared with a sustained release formulation of clonidine alone (author's transl)]. Arndts D, Doevendans J, Arendt G, Rippen G. Arzneimittelforschung; 1981 Sep; 31(11):1954-7. PubMed ID: 7198476 [Abstract] [Full Text] [Related]
18. The kinetics of nifedipine release from porous hydrophilic matrices and the pharmacokinetics in man. Leucuta SE. Pharmazie; 1988 Dec; 43(12):845-8. PubMed ID: 3247376 [Abstract] [Full Text] [Related]
19. Pharmacokinetics and bioavailability of a controlled release amoxicillin formulation. Arancibia A, González G, Icarte A, Arancibia M, Arancibia P. Int J Clin Pharmacol Ther Toxicol; 1987 Feb; 25(2):97-100. PubMed ID: 3557736 [Abstract] [Full Text] [Related]
20. Verapamil stereoisomerism: enantiomeric ratios in plasma dependent on peak concentrations, oral input rate, or both. Karim A, Piergies A. Clin Pharmacol Ther; 1995 Aug; 58(2):174-84. PubMed ID: 7648767 [Abstract] [Full Text] [Related] Page: [Next] [New Search]